Opposing effects of interleukin-1 and transforming growth factor-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells

Experimental Nephrology

Volumn 5, Issue 3, 1997, Pages 233-238

  Wilson, Heather M ^a,b   Haites, Neva E ^a   Booth, Nuala A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Glomerulonephritis; Interleukin 1; Mesangial cells; Plasminogen activator inhibitor type 1; Transforming growth factor

Indexed keywords

INTERLEUKIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; GLOMERULONEPHRITIS; HUMAN; MESANGIUM CELL; PRIORITY JOURNAL;

BASE SEQUENCE; CELLS, CULTURED; DNA PROBES; DRUG INTERACTIONS; FIBRINOLYSIS; GLOMERULAR MESANGIUM; HUMANS; INTERLEUKIN-1; NEPHRITIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030993287     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. El Nahas AM: Growth factors and glomerulosclerosis. Kidney Int 1992;41(suppl 36):15-20.
2. Dinarello CA, Wolff SM: The role of interleukin-1 in disease. N Engl J Med 1993;328:106-113.
3. Border WA, Noble NA: TGF-β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
4. Lacave R, Rondeau E, Ochi S, Delarue F, Schleuning WD, Sraer JD: Characterization of plasminogen activator and its inhibitor in human mesangial cells. Kidney Int 1989;35:806-811.
5. Dano K, Andreasen PA, Grundahl-Hansen J, Kristensen P, Neilsen LS, Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985;44:135-266.
6. Chapman HA, Stone OL: Cooperation between plasmin and elastase in elastin degradation by intact murine macrophages. Biochem J 1984; 222:721-727.
7. Senior RM, Shapiro SD: Introduction: The matrix metalloproteinase family. Am J Respir Cell Mol Biol 1992;119:111-121.
8. Wong AP, Cortez SL, Baricos WH: Role of plasmin and gelatinase in extracellular matrix degradation by cultured rat mesangial cells. Am J Physiol 1992;263:F1112-F1118.
9. Flaumenhaft R, Rifkin DB: The extracellular regulation of growth factor action. Mol Biol Cell 1992;3:1057-1065.
10. Brown PAJ, Wilson HM, Reid FJ, Booth NA, Simpson JG, Morrison L, Power DA, Haites NE: Urokinase is synthesized in vitro by human glomerular epithelial cells but not by mesangial cells. Kidney Int 1994;45:43-47.
11. Glass WF II, Kreisberg JI, Troyer DA: Two-chain urokinase, receptor, and type 1 inhibitor in cultured human mesangial cells. Am J Physiol 1993;264:F532-539.
12. Colucci M, Gesuldo L, Montemurro D, Cavallo LG, Conese M, Mascodo E, Ranieri E, Dipaolo S, Schena FP, Semeraro N: Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors. Thromb Haemost 1993;74:1516-1520.
13. Wilson HM, Haites NE, Reid FJ, Booth NA: Interleukin-1β up-regulates the plasminogen activator/plasmin system in human mesangial cells. Kidney Int 1996;49:1097-1104.
14. Wilson HM, Reid FJ, Brown PAJ, Power DA, Haites NE, Booth NA: Effect of transforming growth factor β1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells. Exp Nephrol 1993;1:343-350.
15. Del Guidice G, Crow MK: Role of TGF-β in systemic autoimmunity. Lupus 1993;2:213-220.
16. Stewart KN, Roy-Chaudhury P, Lumsden L, Jones MJ, Brown PAJ, Macleod AM, Haites NE, Simpson JG, Power DA: Monoclonal antibodies to cultured human glomerular mesangial ceils. J Pathol 1991;163:265-272.
17. Cordell JL, Falini B, Erber WN: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti alkaline phosphatase (APAAP) complexes. J Histochem Cytochem 1984;32:219-229.
18. MacGregor IR, Booth NA: An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1). Thromb Haemost 1988;59:68-72.
19. MacGregor IR, MacDonald S, Davies J, Micklem LR, James K: A monoclonal antibody enzyme linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator. Fibrinolysis 1987; 1:247-252.
20. Andreasen PA, Ricco A, Welinder KG, Douglas R, Sartorio R, Nielsen LS, Oppenheimer C, Blasi F, Dano K: Plasminogen activator inhibitor type-1: Reactive center and amino terminal heterogeneity determined by protein and cDNA sequencing. FEBS Lett 1986;209: 213-218.
21. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, Cold Spring Harbor Press, 1989, pp 6.3-7.84.
22. Loskutoff DJ: Regulation of PAI-1 gene expression Fibrinolysis 1991;5:197-206.
23. Hamilton JA, Wojta J, Gallichio M, McGrath K, Filonzi EL: Contrasting effects of transforming growth factor β and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts. J Immunol 1993;151: 5154-5161.
24. Lyons RM, Keski-Oja J, Moses HL: Proteolytic activation of latent TGF-β from fibroblast conditioned medium. J Cell Biol 1988;106:1654-1665.
25. Border WA, Noble NA: TGF-β in glomerular injury Exp Nephrol 1994;2:13-17.
26. Feng L, Tang WW, Loskutoff DJ, Wilson CB: Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. J Am Soc Nephrol 1993;3:1753-1764.
27. Wahl SM, Hunt DA, Wong HL, et al: TGF-β is a potent immunosuppressive agent that inhibits IL-1 dependent lymphocyte proliferation. J Immunol 1988;140:3026-3032.
28. Turner M, Chantry D, Katsikis P, Berger A, Brennan FM, Feldmann M: Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β. Eur J Immunol 1991;21:1635-1639.
29. Chandrasekhar S, Harvey AK: TGF-β is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem Biophys Res Commun 1988;157:1352-1357.
30. Muhl H, Geiger T, Pignat W, Marki F, van den Bosch H, Cerletts N, Cox D, McMaster G, Vosbeck K, Pfeilschifter J: TGF-β and dexamethasone attenuate group II phospholipase A2 gene expression by interleukin-1 and forskolin in rat mesangial cells. FEBS Lett 1992;302:190-194.
31. Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB: Transforming growth factor-β positively regulates its own expression in normal and transformed cell lines. J Biol Chem 1988;263:7041-7045.